Mitchell P. Kopin 13D/13G Filings for Genetic Technologies Limited (GENE)

Mitchell P. Kopin 13D and 13G filings for Genetic Technologies Limited:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-06-04
4:11 pm
Sale
2020-05-26 13G Genetic Technologies Limited
GENE
Mitchell P. Kopin 3,344,561
1.100%
-4,250,499decrease
(-55.96%)
Filing
2020-04-28
4:44 pm
Purchase
2020-04-19 13G Genetic Technologies Limited
GENE
Mitchell P. Kopin 7,595,060
3.600%
7,595,060increase
(New Position)
Filing